Biblio Discovery — Demo Discovery Service

574 results

Showing 1–20 · 1.16 seconds · RSS

Journal

Drugs in Context

Scopus

ISSN 1740-4398 · BioExcel Publishing Ltd · 574 articles in the index

  1. Journal Article

    The convergent pathway of obstructive lung disease: the disease-modifying potential of dipeptidyl peptidase 1 inhibition in COPD, asthma and bronchiectasis overlap

    Francesco Menzella; Marcello Cottini; Carlo Lombardi et al.

    Drugs in Context, Vol. 15 · 2026 · English · DOAJ Scopus

    The management of chronic obstructive lung diseases, particularly severe asthma, chronic obstructive pulmonary disease (COPD) and non-cystic fibrosis bronchiectasis, is complicated by frequent overlap syndromes such as asthma–bronchiectasis overlap and bronchiectasis– COPD overlap syndrome. These…

  2. Journal Article

    Optimizing care and quality indicators in the management of patients with acute ischaemic heart disease and atherothrombotic stroke: measuring to improve

    José R González-Juanatey; Rafael Vázquez-García; Raquel Campuzano et al.

    Drugs in Context, Vol. 15 · 2026 · English · DOAJ Scopus

    Background: Acute ischaemic heart disease (AIHD) and atherothrombotic stroke are amongst the leading causes of mortality and disability worldwide, sharing pathogenic mechanisms. Quality indicators (QIs) are essential tools for evaluating and optimizing clinical management. The aim of this article…

  3. Journal Article

    Role of a topical hydrogel (Dermatix® wound care gel) in acute and chronic wound management: a case series of real-world experiences and expert opinion from Asia

    Chin Yen Lee; Elizabeth Wei Hsi Chang; Khong Yik Chew et al.

    Drugs in Context, Vol. 15 · 2026 · English · DOAJ Scopus

    Moist wound healing, an established paradigm in the management of wounds, accelerates healing by maintaining an optimal microenvironment. Hydrogels, such as the Dermatix®* Wound Care (DWC) gel, possess fluid-retentive and absorptive properties and provide a moist environment for wound healing. We…

  4. Journal Article

    Ustekinumab-associated morphoea: systematic review of the literature and a real-world case

    Marco Sousa; José Miguel Alvarenga; Ana Maria Lé et al.

    Drugs in Context, Vol. 15 · 2026 · English · DOAJ Scopus

    Ustekinumab, an IL-12/IL-23 inhibitor with an established safety profile, has recently been associated with paradoxical cutaneous immune reactions. Amongst these, morphoea developing during therapy represents a rare but mechanistically relevant phenomenon that highlights cytokine imbalance in skin…

  5. Journal Article

    Emerging concepts in HIV pre-exposure prophylaxis: focus on twice-yearly lenacapavir

    Sarah L Anderson

    Drugs in Context, Vol. 15 · 2026 · English · DOAJ Scopus

    The persistent global burden of HIV and the need for more flexible, durable prevention strategies have accelerated the development of long-acting pre-exposure prophylaxis (PrEP) options. Lenacapavir (LEN), a first-in-class capsid inhibitor, is approved as a twice-yearly subcutaneous injection for…

  6. Journal Article

    Corrigendum: Primary hyperhidrosis: an updated review

    Mahan Maazi; Alexander KC Leung; Joseph M Lam

    Drugs in Context, Vol. 15 · 2026 · English · DOAJ Scopus

    The authors wish to make the following corrections to their article: Maazi M, Leung AKC, Lam JM. Primary hyperhidrosis: an updated review. Drugs Context. 2025;14:2025-3-2. https://doi.org/10.7573/dic.2025-3-2

  7. Journal Article

    Biologics-induced cutaneous pseudolymphomas: a narrative review with an illustrative case of brodalumab-induced pseudolymphoma

    Gustavo Almeida-Silva; Inês Tribolet de Abreu; Filipe Monteiro et al.

    Drugs in Context, Vol. 15 · 2026 · English · DOAJ Scopus

    Cutaneous pseudolymphomas (CPLs) comprise a heterogeneous group of benign lymphoid proliferations that simulate cutaneous lymphomas both clinically and histologically. Numerous causes have been identified, including infections, arthropod bites, tattoos and drugs. With the expanding use of biologic…

  8. Journal Article

    Corrigendum: Role of a topical hydrogel (Dermatix® wound care gel) in acute and chronic wound management: a case series of real-world experiences and expert opinion from Asia

    Chin Yen Lee; Elizabeth Wei Hsi Chang; Khong Yik Chew et al.

    Drugs in Context, Vol. 15 · 2026 · English · DOAJ Scopus

    The authors wish to make the following corrections to their article: Lee CY, Chang EWH, Chew KY, Karupayah V, Latief W, Vi Le A, Tobing D, Vu TPT, Wong KC. Role of a topical hydrogel (Dermatix® wound care gel) in acute and chronic wound management: a case series of real-world experiences and expert…

  9. Journal Article

    Real-world effectiveness of a phlebotonic formulation combining diosmin, Ruscus, Melilotus and Vitis vinifera on symptoms and quality of life in patients with chronic venous and lymphatic disease: results from the VIVEMA Stasis observational study

    Giampiero Avruscio; Carmen Tirrito; Sonia Ragazzo et al.

    Drugs in Context, Vol. 15 · 2026 · English · DOAJ Scopus

    Background: Chronic venous disease and lymphoedema frequently coexist, leading to significant symptom burden and impaired quality of life (QoL). Phlebotonic agents, such as diosmin, Ruscus aculeatus, Melilotus officinalis and Vitis vinifera, have demonstrated complementary anti-inflammatory…

  10. Journal Article

    Antibiotic treatment for neonatal sepsis: changing trends and future directions

    Genevieve PG Fung; Kam Lun E Hon; Alexander KC Leung

    Drugs in Context, Vol. 15 · 2026 · English · DOAJ Scopus

    Background: Neonatal sepsis is a serious and life-threatening condition with high morbidity and mortality, especially in preterm neonates in a Neonatal Intensive Care Unit (NICU). This article provides an updated review on the aetiology and diagnosis of neonatal sepsis, antibiotic management and…

  11. Journal Article

    Standalone NF1: guiding the transition from paediatric to adult care

    Héctor Salvador; Álvaro Lassaletta; Juan Carlos López-Gutiérrez et al.

    Drugs in Context, Vol. 15 · 2026 · English · DOAJ Scopus

    This report summarizes expert and patient-representative perspectives from the meeting entitled ‘Standalone NF1: guiding the transition from paediatric to adult care’, held in Madrid on October 2, 2025. Its primary objective was to examine clinical, organizational and patient- related challenges…

  12. Journal Article

    Corrigendum: SGLT2 inhibitor role in cardio-metabolic–renal diseases: a narrative review of recent evidence and their pharmacological, clinical and economic implications

    Mario Manunta; Giacomo Matteo Bruno; Angelo Ferrantelli et al.

    Drugs in Context, Vol. 15 · 2026 · English · DOAJ Scopus

    The authors wish to make the following corrections to their article: Manunta M, Bruno GM, Ferrantelli A, Ramirez RF, Nardi F. SGLT2 inhibitor role in cardio-metabolic-renal diseases: a narrative review of recent evidence and their pharmacological, clinical and economic implications. Drugs Context…

  13. Journal Article

    Corrigendum: Rheological properties and clinical efficacy of a chemically modified hyaluronic acid for joint health enhancement

    Francesco Benazzo; Andrea Bernetti

    Drugs in Context, Vol. 15 · 2026 · English · DOAJ Scopus

    The authors wish to make the following corrections to their article: Benazzo F, Bernetti A. Rheological properties and clinical efficacy of a chemically modified hyaluronic acid for joint health enhancement. Drugs Context. 2026;15:2025-10-4. https://doi.org/10.7573/dic.2025-10-4

  14. Journal Article

    Corrigendum: New and emerging treatments for PBC-related pruritus

    Sarah L Anderson

    Drugs in Context, Vol. 15 · 2026 · English · DOAJ Scopus

    The authors wish to make the following corrections to their article: Anderson SL. New and emerging treatments for PBC-related pruritus. Drugs Context. 2026;15:2025-12-3. https://doi.org/10.7573/dic.2025-12-3

  15. Journal Article

    Deucravacitinib in dermatology: current indication and existing off-label data

    Michela D’Agostino; Luca Potestio; Nello Tommasino et al.

    Drugs in Context, Vol. 15 · 2026 · English · DOAJ Scopus

    Tyrosine kinase 2 (TYK2) inhibition has recently emerged as a novel therapeutic strategy in dermatology, targeting key cytokine pathways involved in immune-mediated inflammatory diseases. Deucravacitinib, an oral, selective TYK2 inhibitor that binds the regulatory pseudokinase domain, modulates…

  16. Journal Article

    Perioperative immune-checkpoint inhibitors for muscle-invasive bladder cancer

    Albert Jang; Abby L Grier; Iris Y Sheng et al.

    Drugs in Context, Vol. 15 · 2026 · English · DOAJ Scopus

    Muscle-invasive bladder cancer (MIBC) has a high risk of recurrence following radical cystectomy. Neoadjuvant cisplatin-based chemotherapy has been used for decades to lower recurrence rates but a significant proportion of patients still have disease relapse. Recently, immune-checkpoint inhibitors…

  17. Journal Article

    Clinical profile, management and outcomes of patients taking dual pathway inhibition for cardiovascular protection in clinical practice in Latin America. Data from the XATOA registry

    Juan Rene Cornejo-Avendaño; Carlos Novoa; Gerardo Peón et al.

    Drugs in Context, Vol. 15 · 2026 · English · DOAJ Scopus

    Background: The COMPASS trial showed the benefits of dual pathway inhibition (DPI) in patients with atherosclerotic vascular disease. However, the characteristics of patients initiated on DPI have not been previously defined in clinical practice. This study aims to determine the clinical profile…

  18. Journal Article

    Corrigendum: Evaluating the efficacy of curcumin plus serratiopeptidase formulation in inflammatory acne: a quasi-experimental study

    Shakila Junaid; Kiran Naz Khan; Farina Zameer et al.

    Drugs in Context, Vol. 15 · 2026 · English · DOAJ Scopus

    The authors wish to make the following corrections to their article: Junaid S, Naz Khan K, Zameer F, Mudassir M, Bukhari S, Maheshwary N, Khan MA. Evaluating the efficacy of curcumin plus serratiopeptidase formulation in inflammatory acne: a quasi-experimental study. Drugs Context…

  19. Journal Article

    Primary Sjögren’s syndrome-associated interstitial lung disease: a case report with favourable response to tocilizumab

    Negar Naseri; Nadia Jalili; Farzad Rafiei et al.

    Drugs in Context, Vol. 15 · 2026 · English · DOAJ Scopus

    Severe pulmonary involvement in primary Sjögren’s syndrome presents a therapeutic challenge, particularly when conventional immunosuppression is insufficient. We report on the case of a 50-year-old woman with interstitial lung disease and profound gas exchange impairment (DLCO 17%). Despite initial…

  20. Journal Article

    Cloperastine in paediatric and adult cough management: a historical narrative review

    Ovidio Brignoli; Cláudia Henrique Da Costa; José R Jardim et al.

    Drugs in Context, Vol. 15 · 2026 · English · DOAJ Scopus

    Cough is a common symptom associated with many mild and severe medical conditions such as acute and chronic respiratory disorders. However, it can also be linked to extrapulmonary pathologies such as gastroesophageal reflux. Whilst often beneficial in clearing secretions, a persistent dry cough can…